RxDoctor Payments Data

Daniel Boccardo

Cardiovascular Disease · Punta Gorda, FLNPI 1568422913

Payments from drug & device makers

$2,428in general payments, 2019–2025

Across 127 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$376
  • Johnson & Johnson$372
  • Novo Nordisk$370
  • Lilly USA, LLC$309
  • E.r. Squibb & Sons, L.L.C.$194
  • Novartis$129
  • plus $678 from 11 others

What the payments were for

  • Food & beverage$2,416100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,428 in reported general payments places this provider in the 40th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Other cardiovascular disease in Punta Gorda

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →